Traders should prepare for potential volatility following the March 25 earnings release and management commentary, particularly on revenue trends, profitability, and cash burn given the company's small market cap ($249M).
Price Chart
Executive Summary
Journey Medical Corporation (DERM) announced it will release its year-end 2025 financial results on March 25, 2026, followed by a conference call. The press release provides no actual financial data, only logistical details for the upcoming earnings announcement.
Key Facts
- Journey Medical will release year-end 2025 financial results on March 25, 2026, after market close.
- Management will host a conference call and webcast at 4:30 p.m. ET on the same day.
- No financial results, guidance, or operational updates were disclosed in this release.
- The company markets eight FDA-approved dermatology drugs and operates under Fortress Biotech (FBIO).
Financial Impact
No financial data disclosed — impact will depend on actual earnings release.
Risk Factors
- Limited financial transparency ahead of the earnings release increases uncertainty.
- Small-cap biopharma stocks like DERM are prone to sharp post-earnings moves based on revenue and cash flow results.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3258155 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | SC 13G/A | $6.31 | awaiting T+20 | — | $4.96 (−21.39%) |
Aug 15, 2026 10w ago | Institutional Cluster | $6.46 $7.36 | ▲ +13.93% | ▲ +15.91% | $4.96 (−23.22%) |
Aug 12, 2026 10w ago | 8-K | $6.65 $7.23 | ▲ +8.72% | ▲ +10.47% | $4.96 (−25.41%) |
Aug 12, 2026 10w ago | Press Release | $6.65 $7.23 | ▼ −8.72% | ▼ −10.47% | $4.96 (+25.41%) |
May 13, 2026 23w ago | 8-K | $6.35 $6.34 | ▼ −0.16% | ▲ +0.70% | $4.96 (−21.89%) |
May 6, 2026 24w ago | Press Release | $5.00 $6.06 | ▲ +21.20% | ▲ +18.06% | $4.96 (−0.80%) |
Apr 21, 2026 27w ago | Press Release | $4.92 $6.25 | ▲ +27.03% | ▲ +22.12% | $4.96 (+0.81%) |
Mar 25, 2026 30w ago | Press Release | $4.78 $5.15 | ▲ +7.74% | ▼ −2.92% | $4.96 (+3.77%) |
Mar 18, 2026 31w ago | Press Release | $7.12 $5.17 | ▼ −27.39% | ▼ −33.43% | $4.96 (−30.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers